The Diseases of the Century. Can Cancer be Beaten?
Medicine is rapidly advancing, and technical progress isn’t standing still either. The days of the epidemics of infectious diseases that destroyed entire cities in the Middle Ages are gone. Surgery has achieved great results in organ transplantation. Technology has made it possible to carry out comprehensive health diagnostics and perform operations using a laser. Pharmaceuticals will continue to improve and new medicines to be invented. Unheard of diseases have appeared, the consequences of which have not yet been fully investigated. The deterioration of the environment and many psycho-emotional influences have altered the old forms of disease and exacerbated them. Cancer has turned into the disease of the century.
In Russia, work is underway on the federal Fighting Cancer project, the purpose of which is to increase life expectancy. Nuclear medicine today is one of the most rapidly developing and promising areas in modern oncology that offers a wide range of possibilities for personalizing both diagnosis and treatment. The process of import substitution, both in the production of domestic technology and in the development and marketing of domestic radiopharmaceuticals, is subsequently key. What is more profitable – to develop domestic production or import foreign drugs and technologies? Will new domestic pharmaceuticals and medical products appear? What is the role of public corporations in financing basic and applied research in nuclear medicine? How can we ensure the transfer of new technologies within Russia?
Maxim Safonov, Director, Green Capital Alliance; Professor, Russian Presidential Academy of National Economy and Public Administration (RANEPA)
Andrey Kaprin, Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation
Alexander Sergeev, President, Russian Academy of Sciences
Vladimir Uiba, Head, Federal Medical-Biological Agency of the Russian Federation
Sergey Tsyb, First Deputy Minister of Industry and Trade of the Russian Federation
Front row participants
Danil Baryshnikov, Chairman, Committee for Investment in Social Infrastructure, Agency for Social Investment
Yuri Olenin, Deputy Director General for Innovation Management, State Atomic Energy Corporation ROSATOM
Roman Prymula, Deputy Minister of Health of the Czech Republic
Arkady Stolpner, Chairman of the Board, Sergey Berezin Medical Institute